| 2025-10-14 |
详情>>
股本变动：
变动后总股本2096.65万股
|
| 2025-08-21 |
详情>>
业绩披露：
2025年中报每股收益-0.21美元,归母净利润-418.1万美元,同比去年增长83.25%
|
| 2025-08-15 |
详情>>
内部人交易：
Galkin Vladimir股份增加11111.00股
|
| 2025-07-14 |
复牌提示：
2025-07-14 11:24:54 停牌，复牌日期 2025-07-14 11:29:54
|
| 2025-04-28 |
详情>>
业绩披露：
2024年年报每股收益-2.25美元,归母净利润-4332.8万美元,同比去年增长26.55%
|
| 2025-04-07 |
详情>>
拆分方案：
每20.0000合并分成1.0000股
|
| 2024-08-29 |
详情>>
业绩披露：
2024年中报每股收益-0.07美元,归母净利润-2495.4万美元,同比去年增长14.92%
|
| 2024-04-24 |
详情>>
业绩披露：
2023年年报每股收益-0.16美元,归母净利润-5899万美元,同比去年增长-2.72%
|
| 2024-04-24 |
详情>>
业绩披露：
2021年年报每股收益0.10美元,归母净利润3626.20万美元,同比去年增长19.18%
|
| 2023-12-22 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.12美元,归母净利润-4401.2万美元,同比去年增长-60.88%
|
| 2023-08-29 |
详情>>
业绩披露：
2023年中报每股收益-0.08美元,归母净利润-2933.1万美元,同比去年增长-55.45%
|
| 2023-04-27 |
详情>>
业绩披露：
2022年年报每股收益-0.15美元,归母净利润-5742.9万美元,同比去年增长-258.37%
|
| 2023-04-27 |
详情>>
业绩披露：
2020年年报每股收益0.08美元,归母净利润3042.60万美元,同比去年增长279.07%
|
| 2022-12-01 |
详情>>
业绩披露：
2022年三季报(累计)每股收益-0.07美元,归母净利润-2735.7万美元,同比去年增长-191.05%
|
| 2022-08-30 |
详情>>
业绩披露：
2022年中报每股收益-0.05美元,归母净利润-1886.9万美元,同比去年增长-187.39%
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-14 |
股东大会：
将于2021-05-12召开股东大会
会议内容 ▼▲
- 1.adopt an agreement and plan of merger, dated as of October 23, 2020, and as it may be amended from time to time (which we refer to as the merger agreement), by and among the Company, Newegg Inc., a Delaware corporation, or Newegg, and Lightning Delaware Sub, Inc., a Delaware corporation and wholly owned subsidiary of the Company, or Merger Sub, pursuant to which Merger Sub will be merged with and into Newegg, with Newegg continuing as the surviving corporation and a wholly owned subsidiary of the Company (a copy of the merger agreement is attached as Annex A to the accompanying proxy statement/prospectus) (we refer to this proposal as the merger proposal);
2.adopt the equity transfer agreement, dated as of October 23, 2020, and as it may be amended from time to time (which we refer to as the disposition agreement), among Beijing Fenjin Times Technology Development Co., Ltd., or the Purchaser, Lianluo Connection Medical Wearable Device Technology (Beijing) Co., Ltd., or Lianluo Connection, and the Company, pursuant to which we will sell all of our equity interests in Lianluo Connection, our wholly owned subsidiary, to the Purchaser immediately following completion of the merger (a copy of the disposition agreement is attached as Annex E to the accompanying proxy statement/prospectus) (we refer to this proposal as the disposition proposal);
3.redesignate all of our issued and unissued Class A common shares of par value of $0.021848 each and Class B common shares of par value of $0.021848 each into common shares of par value of $0.021848 each on a one to one basis, thus eliminating the Company’s dual class structure (we refer to this proposal as the redesignation proposal);
4.complete a share combination of our issued and outstanding common shares by a ratio of not less than one-for-two and not more than one-for-fifty no later than June 30, 2021, with the exact ratio to be set at a whole number within this range, as determined by our board of directors in its sole discretion (we refer to this proposal as the share combination proposal);
5.increase the number of common shares that the Company is authorized to issue to an unlimited number of common shares (we refer to this proposal as the share increase proposal);
6.change the name of the Company to “Newegg Commerce, Inc.” (we refer to this proposal as the name change proposal);
7.amend and restate our current amended and restated memorandum and articles of association to effect the redesignation proposal, the share combination proposal, the share increase proposal and the name change proposal, as well as certain other amendments described in the accompanying proxy statement/prospectus (a copy of the form of amended and restated memorandum and articles of association is attached as Annex G to the accompanying proxy statement/prospectus) (we refer to this proposal as the charter amendment proposal);
8.approve the adjournment of the special meeting to a later date if necessary to solicit additional proxies if there are not sufficient votes to approve the merger proposal, the disposition proposal, the redesignation proposal, the share combination proposal, the share increase proposal, the name change proposal or the charter amendment proposal at the time of the special meeting, or any adjournment or postponement thereof (we refer to this proposal as the adjournment proposal).
|
| 2020-10-26 |
详情>>
拆分方案：
每8.0000合并分成1.0000股
|
| 2020-03-09 |
股东大会：
将于2020-04-08召开股东大会
会议内容 ▼▲
- 1.To consider and vote upon a proposal to (i) approve a combination of common shares, par value US$0.002731 of the Company (“Common Shares”) at a ratio within the range from one-for-two up to one-for-twenty to be determined by the Board of Directors of the Company (the “Share Combination”) and (ii) amend the Amended and Restated Memorandum and Articles of Association of the Company to provide that the Board of Directors may (a) settle as it considers expedient any difficulty which arises in relation to any combination or consolidation of shares of the Company and (b) determine to compulsorily redeem any fractional shares arising under a share combination of the Company so that (subsequent to such redemption) the shareholder holds a whole number of shares (the “Share Combination Proposal”).
2.Following the approval of the Share Combination Proposal, to consider the vote on a proposal to amend the Amended and Restated Memorandum and Articles of Association of the Company (subject to the determination by the Board of Directors of the Company of a ratio for the Share Combination) to convert all Class B Common Shares into the same number of Class A Common Shares as soon as the Class B shareholders in aggregate beneficially own less than 5% of the total issued and outstanding Class B Common Shares immediately after the effectiveness of the Share Combination.
3.To consider and vote upon a proposal to amend the Amended and Restated Memorandum and Articles of Association of the Company to provide that shareholders of the Company may amend the Memorandum or Articles of Association of the Company by a resolution consented to in writing by the shareholders representing a majority of the votes of the shares entitled to vote thereon.
|
| 2018-07-09 |
股东大会：
将于2018-08-08召开股东大会
会议内容 ▼▲
- 1.To elect Zhitao He and Richard Zhiqiang Chang to serve as Class II members of the board of directors of the Company, each to serve a term expiring at the AGM in 2021;
2.To ratify the appointment of Centurion ZD, CPA as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2018;
3.To consider the transaction of any other business properly coming before the meeting.
|
| 2017-05-08 |
股东大会：
将于2017-06-08召开股东大会
会议内容 ▼▲
- (1)The election of two Class I members of the Board of Directors, each to serve a term expiring at the Annual Meeting of Shareholders in 2020 or until their successors are duly elected and qualified;
(2)The ratification of the appointment of HHC, CPA as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2017;
(3)The amendment and restatement of the Company’s Amended and Restated Memorandum and Articles of Association (the “New M&AAs”) in order that the Company’s authorized share capital be re-classified and re-designated into 50,000,000 Common Shares of par value of US$0.002731 each, of which 37,888,889 would be designated as Class A Common Shares of par value of US$0.002731 each (the “Class A Common Shares”) and 12,111,111 be designated as Class B Common Shares of par value of US$0.002731 each (the “Class B Common Shares”);
(4)Following the approval of the New M&AAs, as proposed in Proposal Three, the conversion of all Class B Common Shares into the same number of Class A Common Shares as soon as the Class B shareholders in aggregate beneficially own less than 605,555 Class B Common Shares, which is equivalent to 5% of the total issued and outstanding Class B Common Shares as of the expected date of effectiveness of the New M&AA;
(5)The approval of the form of the Company’s New M&AA;
(6)The transaction of any other business properly coming before the meeting.
|
| 2016-11-22 |
股东大会：
将于2016-12-19召开股东大会
会议内容 ▼▲
- (1)To elect one Class III member of the Board of Directors, to serve a term expiring at the Annual Meeting of Shareholders in 2019 or until his successor is duly elected and qualified;
(2)To ratify the appointment of HHC, CPA as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2016;
(3)To transact any other business properly coming before the meeting.
|
| 2013-11-29 |
股东大会：
将于2013-12-19召开股东大会
会议内容 ▼▲
- (1) To elect one Class III member of the Board of Directors, to serve a term expiring at the Annual Meeting of Shareholders in 2016 or until his successor is duly elected and qualified;
(2) To ratify the appointment of Friedman LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2013;
(3) To approve the Company’s 2013 Share Incentive Plan;
(4) To transact any other business properly coming before the meeting.
|